Richard Baron, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Hooper Rd, Endwell, NY 13760 Phone: 607-757-0444 Fax: 607-748-8984 |
News Archive
US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.
By wearing a unique weighted back support device and participating in a special exercise program, women over 60 with osteoporosis-caused curvature of the spine improved their balance and experienced diminished back pain, giving researchers at Mayo Clinic a promising therapy to reduce falls among this population.
Pancreatic cancer tumors addicted to mutant Kras signaling for their growth and progression have a ready-made substitute to tap if they're ever forced to go cold-turkey on the mutant oncogene, scientists at The University of Texas MD Anderson Cancer Center report in the journal Cell.
Standard guidelines for stroke treatment currently recommend clot removal only within six hours of stroke onset. But a milestone study with results published today in the New England Journal of Medicine shows that clot removal up to 24 hours after stroke led to significantly reduced disability for properly selected patients.
Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.
› Verified 3 days ago